These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 11153417)

  • 21. Interferon therapy in HCV-positive mixed cryoglobulinaemia: viral and host factors contributing to efficacy of the therapy.
    Mazzaro C; Carniello GS; Colle R; Doretto P; Mazzi G; Crovatto M; Santini GF; Tulissi P; Gregoretti M; Mazzoran L; Russo A; Silvestri F; Pozzato G
    Ital J Gastroenterol Hepatol; 1997 Aug; 29(4):343-50. PubMed ID: 9476189
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Donor hepatitis C antibody virus testing in renal transplantation.
    Mendez R; Aswad S; Bogaard T; Khetan U; Asai P; Martinez A; Flores N; Mendez RG
    Transplant Proc; 1993 Feb; 25(1 Pt 2):1487-90. PubMed ID: 7680167
    [No Abstract]   [Full Text] [Related]  

  • 23. [Hepatitis B and C: biology and molecular diagnosis].
    Blum HE
    Verh Dtsch Ges Pathol; 1994; 78():94-103. PubMed ID: 7534024
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Occult hepatitis C virus infection in patients in whom the etiology of persistently abnormal results of liver-function tests is unknown.
    Castillo I; Pardo M; Bartolomé J; Ortiz-Movilla N; Rodríguez-Iñigo E; de Lucas S; Salas C; Jiménez-Heffernan JA; Pérez-Mota A; Graus J; López-Alcorocho JM; Carreño V
    J Infect Dis; 2004 Jan; 189(1):7-14. PubMed ID: 14702147
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Epidemiology and clinical aspects of chronic viral hepatitis].
    Heintges T; Niederau C; Niederau M; Stremmel W
    Z Gastroenterol; 1993 Nov; 31 Suppl 5():42-5. PubMed ID: 8197800
    [No Abstract]   [Full Text] [Related]  

  • 26. [Planning and significance of tests to confrim the presence of anti-hepatitis-C antibodies in blood donors. Spanish Study Group for Blood Donors at Risk].
    León P; Echevarría JM
    Sangre (Barc); 1999 Oct; 44(5):309-14. PubMed ID: 10618905
    [No Abstract]   [Full Text] [Related]  

  • 27. [Hepatitis C virus antibodies (anti-HCV) prevalence rate in anti-HBc-negative blood donors].
    Baur P; Roelcke D
    Beitr Infusionsther; 1991; 28():25-6. PubMed ID: 1725631
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Prevalence and follow-up of hepatitis C virus infection in pregnancy].
    Hillemanns P; Langenegger P; Langer BC; Knitza R; Hasbargen U; Hepp H
    Z Geburtshilfe Neonatol; 1998; 202(3):127-30. PubMed ID: 9715529
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Early detection of de novo hepatitis C infection in patients after liver transplantation by reverse transcriptase polymerase chain reaction.
    Mateo R; Demetris A; Sico E; Frye C; Wang LF; el-Sakhawi Y; Reilly M; Ehrlich GD; Cooper D; Fung J
    Surgery; 1993 Aug; 114(2):442-8. PubMed ID: 7688155
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Viral hepatitis C].
    Zeuzem S; Roth WK; Herrmann G
    Z Gastroenterol; 1995 Feb; 33(2):117-32. PubMed ID: 7536996
    [TBL] [Abstract][Full Text] [Related]  

  • 31. In situ identification of hepatitis C virus RNA in muscle.
    Ito H; Ito H; Nagano M; Nakano S; Shigeyoshi Y; Kusaka H
    Neurology; 2005 Mar; 64(6):1073-5. PubMed ID: 15781833
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Rational use of polymerase chain reaction--based detection of viral genomes in patients with serologic markers of hepatitis B or C virus infection.
    Pfeffel F; Oesterreicher C; Penner E; Ferenci P; Sillaber C; Fiedler R; Müller C
    Wien Klin Wochenschr; 1997 Jan; 109(1):20-4. PubMed ID: 9037744
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Tissue hepatitis C virus RNA quantification and protein expression help identify early hepatitis C virus recurrence after liver transplantation.
    D'Errico-Grigioni A; Fiorentino M; Vasuri F; Gruppioni E; Fabbrizio B; Zucchini N; Ballardini G; Morelli C; Pinna AD; Grigioni WF
    Liver Transpl; 2008 Mar; 14(3):313-20. PubMed ID: 18306349
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Histopathology of viral hepatitis C].
    Chevallier M; Degott C
    Pathol Biol (Paris); 1995 Oct; 43(8):703-8. PubMed ID: 8745592
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Latin American Association for the Study of the Liver Practice Guidelines. Diagnosis, management, and treatment of hepatitis C.
    Latin American Association for the Study of the Liver
    Ann Hepatol; 2010; 9 Suppl():8-26. PubMed ID: 20713990
    [No Abstract]   [Full Text] [Related]  

  • 36. Occult hepatitis C virus infection in hemodialysis patients: examining the evidence.
    Kamar N; Nicot F; Izopet J; Rostaing L
    Am J Kidney Dis; 2009 Jul; 54(1):10-2. PubMed ID: 19324484
    [No Abstract]   [Full Text] [Related]  

  • 37. The discovery of the NANB hepatitis virus by gene technology.
    Decker RH
    Beitr Infusionsther; 1992; 30():6-12. PubMed ID: 1284768
    [No Abstract]   [Full Text] [Related]  

  • 38. Procollagen-III peptide and chronic viral C hepatitis.
    Jeffers LJ; Coelho-Little ME; Cheinquer H; Vargas C; Civantos F; Alvarez L; Reddy KR; Parker T; de Medina M; Li X
    Am J Gastroenterol; 1995 Sep; 90(9):1437-40. PubMed ID: 7661165
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Hepatitis C virus: the virus responsible of the majority of non A non B hepatitis. First Part: Biology of the virus and clinical and serological aspects of hepatitis C].
    Lunel F
    Gastroenterol Clin Biol; 1992; 16(6-7):518-25. PubMed ID: 1326461
    [No Abstract]   [Full Text] [Related]  

  • 40. [Association of porphyria cutanea tarda and hepatitis C virus].
    Martín-Vivaldi Martínez R; Espinosa Aguilar MD; Sánchez Sanchéz-Vizcaíno J; Quintero Fuentes D; Nogueras López F; López de Hierro Ruiz M
    Rev Esp Enferm Dig; 1996 Mar; 88(3):213-6. PubMed ID: 8645516
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.